Latest autoimmune disease Stories
Renewal of U.S. Government Special Diabetes Program Will Ensure Progress toward Better Treatments and a Cure for Type 1 Diabetes NEW YORK, Nov. 5, 2010 /PRNewswire-USNewswire/ -- Thanks to significant research advances in recent years, people living with type 1 diabetes have received better treatments and therapies. Scientists have made headway in uncovering the possible cause of type 1 diabetes, and in their efforts to find ways to prevent, treat, or reverse the autoimmune disease and its...
Survey finds emotional impact of the disease greatly affects children PORTLAND, Ore., Oct. 25 /PRNewswire-USNewswire/ -- Almost half of children with psoriasis surveyed by the National Psoriasis Foundation report being bullied at least once in the last six months. The Psoriasis Foundation surveyed parents of kids with psoriatic disease and found that 44 percent of children have been bullied by their peers, and 38 percent of kids say the abuse was a direct result of their disease. The survey...
A deficiency in one of the immune system's enzymes affects the severity of autoimmune diseases such as MS, and explains why the course of these diseases can vary so much. New findings give an insight into how this enzyme deficiency can be diagnosed, and could lead to new medicines, reveals a thesis from the Sahlgrenska Academy.Multiple sclerosis (MS) and Guillain-Barré syndrome (GBS) "“ the two autoimmune diseases covered by the thesis "“ can follow vastly different courses, with...
"The Hygiene Hypothesis," the Family Connection, Environmental Triggers and "The Global State of Autoimmunity" Are Focus DETROIT, Sept. 16 /PRNewswire-USNewswire/ -- Emmy-nominated actress, Kellie Martin, star of "ER," "Life Goes On" and the summer NBC movie "The Jensen Project" will be a featured speaker at "The Global State of Autoimmunity" conference hosted by the NGO Health Committee with the United Nations (UN) in partnership with the American Autoimmune Related Diseases Association,...
University of Michigan scientists receive first 1,250 research samples PORTLAND, Ore., Sept. 1 /PRNewswire-USNewswire/ -- Millions of Americans struggling with psoriasis and psoriatic arthritis are one step closer to a cure with the first-ever release of National Psoriasis Victor Henschel BioBank DNA samples for use in psoriasis research. The samples will allow scientists to uncover the unknowns about the genetics of psoriatic disease and its causes. James T. Elder, M.D., Ph.D., professor...
PsoMe.org is the first to connect kids with psoriatic disease PORTLAND, Ore., July 15 /PRNewswire-USNewswire/ -- Hundreds of children around the country living with psoriasis and psoriatic arthritis have a new resource to help them cope with the psychological and social effects of these illnesses with the launch of the first website for kids with psoriatic disease -- www.PsoMe.org. Studies show that children with psoriasis are more likely to be alienated, called names, teased and bullied...
AURORA, Colo., July 8 /PRNewswire/ -- Western States Biopharmaceuticals, Inc. (WSBI), a privately-held biotechnology company focusing on the development of novel therapies to treat inflammatory disease, and the University of Colorado announced today that they have entered into a licensing agreement for approaches to inhibiting newly discovered T cell Cytokine Inducing Surface Molecules, or TCISM(TM) autoimmune disease drug discovery targets. WSBI's Chief Scientific Officer and a discoverer...
LOS ANGELES, June 2 /PRNewswire/ -- Two new studies suggest that excess levels of a protein associated with inflammation, TNF, may produce cognitive decline. TNF regulates both inflammation and brain function. TNF is elevated in the blood in many autoimmune diseases, and in the fluid surrounding the brain in Alzheimer's disease. The new studies, from medical centers in Taiwan and the Netherlands, examined cognitive function in patients with either of two autoimmune diseases, rheumatoid...
HAYWARD, Calif., March 23 /PRNewswire-FirstCall/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has hired Georgina Kilfoil to the newly created position of Senior Vice President of Product Development and Clinical Operations. "Georgina brings over 18 years of project management and clinical research experience, making her a valuable and welcome addition to our senior...
SOUTH SAN FRANCISCO, Calif., March 17 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to present a company overview at the Barclays Capital 2010 Global Healthcare Conference in Miami, Florida on Tuesday, March 23 at 10:45 a.m. EDT. To access the live audio webcast or the subsequent archived recording, log on to www.rigel.com. Please connect to Rigel's website several...
